会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 33. 发明授权
    • Cholesterol ester hydrolase inhibitors
    • 胆固醇酯水解酶抑制剂
    • US5602151A
    • 1997-02-11
    • US572993
    • 1995-12-15
    • Richard E. MewshawThomas J. CommonsDonald P. Strike
    • Richard E. MewshawThomas J. CommonsDonald P. Strike
    • C07C271/40C07D295/205A61K31/445C07D211/06
    • C07D295/205C07C271/40C07C2101/14C07C2103/93
    • The compounds of the formula: ##STR1## in which X is ##STR2## where R.sup.7 is hydrogen, alkyl, hydroxy, alkanoyloxy, hydroxyalkyl, hydroxycarbonyl, alkoxycarbonyl, phenyl or substituted phenyl, in which the substituent is alkyl, alkoxy, halo, nitro, cyano, haloalkyl, perhaloalkyl or dialkylaminoalkyl; R.sup.8 is hydrogen or alkyl or R.sup.7 and R.sup.8 taken together are polymethylene; R.sup.9 is hydrogen, alkyl, phenyl or substituted phenyl, in which the substituent is alkyl, alkoxy, halo, nitro, cyano or perhaloalkyl; R.sup.10 is hydrogen, alkyl or gemdialkyl; n is one of the integers 0, 1 or 2; and R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are, independently, hydrogen, alkyl, alkoxy, halo, nitro, cyano or perhaloalkyl, alkoxycarbonyl or hydroxycarbonyl; and when X is --NR.sup.9 -- or R.sup.7 is an amino alkyl group, a pharmaceutically acceptable salt thereof; are useful as inhibitors of cholesterol ester hydrolase.
    • 其中X为的化合物,其中R 7为氢,烷基,羟基,烷酰氧基,羟基烷基,羟基羰基,烷氧基羰基,苯基或取代的苯基,其中取代基为烷基,烷氧基,卤素,硝基 ,氰基,卤代烷基,全卤代烷基或二烷基氨基烷基; R8是氢或烷基或R7和R8一起是聚亚甲基; R9是氢,烷基,苯基或取代的苯基,其中取代基是烷基,烷氧基,卤素,硝基,氰基或全卤代烷基; R10为氢,烷基或偕二烷基; n是整数0,1或2之一; 并且R 3,R 4,R 5和R 6独立地为氢,烷基,烷氧基,卤素,硝基,氰基或全卤代烷基,烷氧基羰基或羟基羰基。 当X是-NR9-或R7是氨基烷基时,其药学上可接受的盐; 可用作胆固醇酯水解酶的抑制剂。
    • 34. 发明授权
    • N,N',N'-trisubstituted-5-bisaminomethylene-1,3-dioxane-4,6-dione
inhibitors of acyl-CoA:cholesterol-acyl transferase
    • 酰基辅酶A的N,N',N'-三取代-5-二氨基亚甲基-1,3-二恶烷-4,6-二酮抑制剂:胆固醇 - 酰基转移酶
    • US5399697A
    • 1995-03-21
    • US152613
    • 1993-11-15
    • William F. FobareDonald P. Strike
    • William F. FobareDonald P. Strike
    • C07D319/06C07D405/12C07F7/18C07D215/38C07D215/40
    • C07D319/06C07D405/12C07F7/1852
    • The compounds of the formula: ##STR1## in which X, Y and Z are, independently, hydrogen, halogen, hydroxy, nitro, cyano, carboxyl, trifluoromethyl, phenyl, amino, alkylamino, dialkylamino, alkyl, alkoxy or phenylalkyloxy; R.sub.1 is thienyl, imidazolyl, thiazolyl, pyridinyl, quinolinyl, pyrimidinyl, pyrazinyl, benzamidazolyl, phenylalkylpiperidinyl or morpholino or athaae analogous hetercyclic groups with from one to three substituents selected from halogen, hydroxy, nitro, cyano, carboxyl, trifluoromethyl, phenyl, amino, alkylamino of 1 to 6 carbon atoms, dialkylamino in which each alkyl group has 1 to 6 carbon atoms, alkyl of 1 to 6 carbon atoms, or alkoxy of 1 to 6 carbon atoms; R.sub.2 is hydrogen, alkyl, cycloalkyl, phenyl, benzyl or substituted phenyl or benzyl in which said substituent is alkyl, alkoxy, halogen, cyano, trifluoromethyl amino, nitro, alkylamino or dialkylamino; and a pharmaceutically acceptable salt thereof; are ACAT inhibitors, some of which possess antioxidant properties.
    • 下式的化合物:其中X,Y和Z独立地为氢,卤素,羟基,硝基,氰基,羧基,三氟甲基,苯基,氨基,烷基氨基,二烷基氨基,烷基,烷氧基或苯基烷氧基。 R 1是具有1至3个选自卤素,羟基,硝基,氰基,羧基,三氟甲基,苯基,氨基,苯基,噻唑基,噻唑基,噻唑基,吡啶基,喹啉基,嘧啶基,吡嗪基,苯并咪唑基,苯基烷基哌啶基或吗啉代或类似的杂环基, 1至6个碳原子的烷基氨基,每个烷基具有1至6个碳原子的二烷基氨基,1至6个碳原子的烷基或1至6个碳原子的烷氧基; R 2是氢,烷基,环烷基,苯基,苄基或取代的苯基或苄基,其中所述取代基是烷基,烷氧基,卤素,氰基,三氟甲基氨基,硝基,烷基氨基或二烷基氨基; 及其药学上可接受的盐; 是ACAT抑制剂,其中一些具有抗氧化性质。
    • 35. 发明授权
    • N,N',N'-trisubstituted-5-bisaminomethylene-1,3-dioxane-4,6-dione
inhibitors of acyl-CoA: cholesterol-acyl transferase
    • 酰基辅酶A的N,N',N'-三取代-5-二氨基亚甲基-1,3-二恶烷-4,6-二酮抑制剂:胆固醇 - 酰基转移酶
    • US5281714A
    • 1994-01-25
    • US998213
    • 1992-12-30
    • William F. FobareDonald P. Strike
    • William F. FobareDonald P. Strike
    • C07D319/06C07D405/12C07F7/18
    • C07D319/06C07D405/12C07F7/1852
    • The compounds of the formula: ##STR1## in which X, Y and Z are, independently, hydrogen, halogen, hydroxy, nitro, cyano, carboxyl, trifluoromethyl, phenyl, amino, alkylamino, dialkylamino, alkyl, alkoxy or phenylalkyloxy; R.sub.1 is thienyl, imidazolyl, thiazolyl, pyridinyl, quinolinyl, pyrimidinyl, pyrazinyl, benzamidazolyl, phenylalkylpiperidinyl or morpholino or athaae analogous hetercyclic groups with from one to tahree substituents selected from halogen, hydroxy, nitro, cyano, carboxyl, trifluoromethyl, phenyl, amino, alkylamino of 1 to 6 carbon atoms, dialkylamino in which each alkyl group has 1 to 6 carbon atoms, alkyl of 1 to 6 carbon atoms, or alkoxy of 1 to 6 carbon atoms; R.sub.2 is hydrogen, alkyl, cycloalkyl, phenyl, benzyl or substituted phenyl or benzyl in which said substituent is alkyl, alkoxy, halogen, cyano, trifluoromethyl amino, nitro, alkylamino or dialkylamino; and a pharmaceutically acceptable salt thereof; are ACAT inhibitors, some of which possess antioxidant properties.
    • 下式的化合物:其中X,Y和Z独立地为氢,卤素,羟基,硝基,氰基,羧基,三氟甲基,苯基,氨基,烷基氨基,二烷基氨基,烷基,烷氧基或苯基烷氧基。 R 1是具有1至多个取代基的选自卤素,羟基,硝基,氰基,羧基,三氟甲基,苯基,氨基,噻唑基,噻唑基,噻唑基,吡啶基,喹啉基,嘧啶基,吡嗪基,苯并咪唑基,苯基烷基哌啶基或吗啉代或类似的杂环基团。 1至6个碳原子的烷基氨基,每个烷基具有1至6个碳原子的二烷基氨基,1至6个碳原子的烷基或1至6个碳原子的烷氧基; R 2是氢,烷基,环烷基,苯基,苄基或取代的苯基或苄基,其中所述取代基是烷基,烷氧基,卤素,氰基,三氟甲基氨基,硝基,烷基氨基或二烷基氨基; 及其药学上可接受的盐; 是ACAT抑制剂,其中一些具有抗氧化性质。
    • 40. 发明授权
    • C-3' thiadiazinyl cephalosporin analogs
    • C-3'噻二嗪基头孢菌素类似物
    • US4728733A
    • 1988-03-01
    • US801460
    • 1985-11-25
    • Jerauld S. SkotnickiDonald P. Strike
    • Jerauld S. SkotnickiDonald P. Strike
    • A61K31/545C07D501/36C07D501/46
    • C07D501/46
    • There are disclosed novel antibacterial compounds having the formula ##STR1## wherein R is hydrogen, lower alkyl, lower alkenyl, lower alkynyl, cyclo lower alkyl, aryl of 6-12 carbon atoms, all the said foregoing groups being optionally substituted with carboxy, lower alkoxycarbonyl, phenoxycarbonyl, amino, mono- or di-lower alkyl substituted amino, hydroxy, lower alkoxy, phenoxy, carbamoyl, lower alkyl carbonyl, benzoyl, cyano, nitro, formamido, lower alkanoylamino or benzamido;R.sup.1 is hydrogen, lower alkyl or an alkali metal cation;A is ##STR2## R.sup.2 and R.sup.3 are each individually hydrogen, lower alkyl, carboxy, lower alkoxycarbonyl, cyano, nitro, trifluoromethyl, phenyl or naphthyl; or R.sup.2 and R.sup.3 taken together represent ##STR3## or a 5- or 6- membered unsaturated aza-, diaza-, triaza-, tetraza-, thia-, thiaza-, oxathia-, oxathiaza-, oxa-, dioxa-, oxaza- or oxadiazacyclic moiety; and the dotted line denotes an optional double bond; andR.sup.4 is hydrogen, lower alkyl, phenyl or naphthyl.
    • 公开了具有式“IMAGE”的新型抗菌化合物,其中R是氢,低级烷基,低级烯基,低级炔基,环低级烷基,6-12个碳原子的芳基,所有上述基团任选被羧基取代,低级 烷氧基羰基,苯氧基羰基,氨基,一或二低级烷基取代的氨基,羟基,低级烷氧基,苯氧基,氨基甲酰基,低级烷基羰基,苯甲酰基,氰基,硝基,甲酰氨基,低级烷酰氨基或苯甲酰氨基。 R1是氢,低级烷基或碱金属阳离子; A是图像,R 2和R 3各自独立地为氢,低级烷基,羧基,低级烷氧基羰基,氰基,硝基,三氟甲基,苯基或萘基。 或者R 2和R 3一起代表一个或多个5-或6-元不饱和氮杂 - ,二氮杂 - ,三氮杂 - ,四嗪 - ,硫杂 - ,硫杂 - 氧化硫 - 氧基硫杂 - 氧杂 - 二氧杂环己二烯 - 或恶二氮环部分; 虚线表示任选的双键; R4是氢,低级烷基,苯基或萘基。